Dr. Cassandra Taylor, Quality Considerations for Cannabis and Cannabis-Derived Products for Use in Clinical Trials

May 2022

Cassandra Taylor, Ph.D. is a Chemist at U.S. Food and Drug Administration within the Center for Drug Evaluation and Research (CDER) and is a member of the Botanical Review Team (BRT) residing within the Office of Pharmaceutical Quality (OPQ) and serves as an expert resource on all botanical issues. Dr. Taylor received her B.S. in Chemistry from St. Francis University (2005), and her Ph.D. in Analytical Chemistry from the University of Maryland (2014). Dr. Taylor has evaluated over 100 botanical drug submissions across CDER’s clinical divisions, with a focus on cannabis submissions. She serves as a cannabis subject matter expert (SME) for CDER and across FDA, concentrating on the botanical and quality aspects of cannabis. Dr. Taylor is technical lead on the draft FDA guidance for industry titled “Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research.” She leads and coordinates the CDER Cannabis working group and leads many cannabis initiatives within CDER and FDA. Dr. Taylor is an active SME in the FDA cross-agency cannabis working group, Cannabis Products Committee (CPC). She collaborates with colleagues across FDA to help close substantial knowledge gaps about the science, safety, and quality of cannabis and cannabis-derived products.

Previous Webinars

CANCELLED Resat Cinar, BPharm, PhD, MBA

February 13th at 1:00PM MST CANCELLED

Cannabinoid Receptor 1 in Lungs: Driving under the influence of endocannabinoids and cannabinoids towards inflammatory lung diseases

Dr Resat Cinar is a principal investigator and the chief of Section on Fibrotic Disorders at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH) since January 2021 […]

Read More »

Kevin Boehnke, PHD.

January 9th at 1:00PM MST

Thoughtful approaches to chronic pain and cannabis research

Dr. Kevin Boehnke is an Assistant Professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. Kevin received his doctorate from the University of Michigan School of Public Health in Environmental Health Sciences in 2017. He is also a […]

Read More »

David Gorelick, MD, PHD.

December 12th at 1:00PM MST

Cannabis-related psychiatric disorders

Dr. David Gorelick earned his bachelor degree in psychology from Cornell University and his medical degree and PhD in pharmacology from Albert Einstein College of Medicine. After completing his psychiatry residency at UCLA, he remained on the faculty until 1989, when he moved to the NIDA Intramural Research […]

Read More »

Kimberly Gwinn, PhD

February 19, 2025 at 11:00 AM MST

Title “Exploring Nematode Interactions with Cannabis”

Kimberly D. Gwinn is a Professor of Entomology and Plant Pathology at the University of Tennessee. Her lab currently investigates natural products that are produced by plants and microbes and their uses as medicines and as bio-pesticides. She has also explored the […]

Read More »

Kenneth Frost, PhD.

Wed, Nov. 20, 11:00AM MST

Recognizing diseases of hemp grown in the U.S. Pacific Northwest

Ken Frost is an Associate Professor and Extension Plant Pathologist in the Department of Botany and Plant Pathology at Oregon State University. His research and extension program is located at the Hermiston Agricultural Research and Extension Center in Hermiston, Oregon, […]

Read More »

Joshua Kellogg, PhD.

Wed, Oct. 16, 11:00AM MST

Cannabinoids: From the Plant to the Gut

Dr. Joshua Kellogg is an Assistant Professor at the Pennsylvania State University, where his lab employs transdisciplinary approaches at the interface of analytical chemistry, chemical biology, natural product chemistry, and molecular biology to further human, plant, animal, and environmental health. His team works to […]

Read More »